Reply to “Double-Carbapenem Therapy Not Proven To Be More Active than Carbapenem Monotherapy against KPC-Positive Klebsiella pneumoniae”

Antzeko izenburuak

• Double-Carbapenem Therapy Not Proven To Be More Active than Carbapenem Monotherapy against KPC-Positive Klebsiella pneumoniae
  nork: Thomson, Kenneth S.
  Argitaratua: (2012)
• Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
  nork: Bulik, Catharine C., et al.
  Argitaratua: (2011)
• Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital
  nork: Leavitt, Azita, et al.
  Argitaratua: (2007)
• The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population
  nork: Esteban-Cantos, Andrés, et al.
  Argitaratua: (2017)
• Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
  nork: Landman, David, et al.
  Argitaratua: (2009)